MRPHF research" "The Company had a net decrease in cash position for the current three months ended September 30, 2017 of $2.56 million compared to a net decrease in restated cash of $1.55 million for the same period in the prior year. The decrease in cash is primarily due to land acquisition of $1.06 million construction costs of $0.41 and an equity purchase in Veritas Pharma Inc. of $1.08 million. $1.7 million of cash was used for operations offset by proceeds received primarily from warrants of $5.5 million. As at September 30, 2017 the Company had a cash balance of $3.19 million and working capital of $6.31 million."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.